Cardiovascular Diseases

A Niacin Metabolite Linked to CVD Risk

Studies suggested that terminal breakdown products of excess niacin (vitamin B3 or nicotinic acid) are associated with residual cardiovascular disease (CVD) risk and provided a possible explanation for the ‘niacin paradox’—the observation that the LDL lowering induced by niacin fails to achieve the expected reduction in CVD risks. Untargeted metabolomics analysis of fasting plasma from stable cardiac patients in a prospective discovery cohort (n = 1,162 total, 422 females) suggested that niacin metabolism was associated with incident major adverse cardiovascular events (MACE). Serum levels of the terminal metabolites of excess niacin, N1-methyl-2-pyridone-5-carboxamide (2PY) and N1-methyl-4-pyridone-3-carboxamide (4PY), were associated with increased 3-year MACE risk in two validation cohorts (US n = 2,331 total, 774 females; European n = 832 total, 249 females) (adjusted hazard ratio (HR)  for 2PY: 1.64 and 2.02, respectively; for 4PY: 1.89 and 1.99, respectively). Phenome-wide association analysis of the genetic variant rs10496731 significantly associated with both 2PY and 4PY levels revealed an association of the variant with levels of soluble vascular adhesion molecule 1 (sVCAM-1). Further meta-analysis confirmed association of rs10496731 with sVCAM-1 (n = 106,000 total, 53,075 females). Moreover, sVCAM-1 levels were significantly correlated with both 2PY and 4PY in a validation cohort (n = 974 total, 333 females). Lastly, treatment with physiological levels of 4PY, but not its structural isomer 2PY, induced expression of VCAM-1 and leukocyte adherence to vascular endothelium in mice. Taken together, the findings suggest that the terminal breakdown products of excess niacin, 2PY and 4PY, are associated with residual CVD risk, and suggest an inflammation-dependent mechanism underlying the clinical association between 4PY and MACE. Only a portion of attributable CVD risk is accounted for by established risk factors with high residual CVD risk, indicating that additional factors are involved in CVD. Source: https://www.nature.com/

hyangiu

Recent Posts

Circadian Depression Subtype Linked to More Severe Symptoms and Poorer Antidepressant Response

A circadian subtype of depression is associated with earlier disease onset, more severe clinical features,…

4 days ago

Frequent and Unintentional Daytime Napping Linked to Higher Dementia Risk

A longitudinal study of 995 U.S. older adults found that frequent and unintentional daytime napping…

5 days ago

A Common CD36 Variant of Dilated Cardiomyopathy in Individuals of African Ancestry

A multicohort genetic association study found that the ancestry-enriched CD36 Y325* variant accounted for a…

5 days ago

Exercise Prescription: A Core Component of CVD Prevention and Treatment

An American College of Cardiology scientific statement emphasizes that exercise should be prescribed as a…

5 days ago

Low-Fat Vegan Diet Improves Metabolic Health in T2D

A 16-week low-fat vegan diet was associated with significant reductions in body weight, visceral fat,…

2 weeks ago

Intensive BP Lowering Reduced Cardiovascular Risk but Increased eGFR Decline

A systematic review and meta-analysis of 27 studies involving 88,830 participants found that intensive blood…

2 weeks ago

This website uses cookies.